Normative Assessment of Adaptable Mouthguards.
ENORMPIBA
1 other identifier
interventional
14
0 countries
N/A
Brief Summary
The aim of this study is to the validate adaptable mouthguards prototypes, patented by Bordeaux University and Bordeaux University Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2011
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2012
CompletedFirst Submitted
Initial submission to the registry
August 13, 2019
CompletedFirst Posted
Study publicly available on registry
August 14, 2019
CompletedAugust 14, 2019
August 1, 2019
10 months
August 13, 2019
August 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Impact on ventilatory flow rate by minute
Average of measured values in one minute, compared to maximum aerobic reference speed of the subject Modification of the ventilatory flow rate by min
At Week 51
Impact on O2 consumption
Average of measured values in one minute, compared to reference of the subject
At Week 51
Impact on respiratory rate
Average of measured values in one minute, compared to reference of the subject
At Week 51
Impact on current volume
Average of measured values in one minute, compared to reference of the subject
At Week 51
Impact on CO2 production
Average of measured values in one minute, compared to reference of the subject
At Week 51
Impact on comfort according an analogical visual scale for 11 criteria
According an analogical visual scale (from 0 to 10) for 11 criteria (retention, muco-gingival appearance, mouth opening height, volume of mouthguards, nausea, phonation, open mouth ventilation, tight jaw ventilation, salivation, masticatory muscles, temporomandibular joint)
At Week 51
Impact on electromyographic recording
The electromyographic activity will be amplified and filtered (bandwidth 10-1000 Hz). The signals will be digitized using a CED 1401 interface coupled to a microcomputer that is controlled by the "SPIKE2" software. The digitization frequency will be 2,000 Hz. The software "SPIKE2" will then calculate what is called "integrated electromyogram": the electromyographic signals will be rectified and filtered with a moving average having a period of 0,2 seconds.
At Week 52
Study Arms (1)
SIngle arm
EXPERIMENTALThe research is based on a population of men and women practicing a sport at risk of oral trauma.
Interventions
Validate a prototype of Adaptable Intra-Oral Protections patented by Bordeaux University and Bordeaux University Hospital according to 3 levels (ventilation, comfort, cervical muscle activity).
Eligibility Criteria
You may qualify if:
- Subject aged 18 to 35,
- Subject affiliated to a social security,
- Subject who has signed the free and informed consent form.
You may not qualify if:
- Subject with a pathology incompatible with the performance of the test, namely: Recent infarction,Threat syndrome, blood pressure resting\> 200/120 mmHg, uncompensated cardiac insufficiency, atrioventricular block 3rd degree acquired, Myocarditis, Pericarditis, Endocarditis, Aortic Dissection, Intracardiac Tumor or Thrombus, Deep Vein Thrombosis, Pulmonary Embolism,
- Subject under B-mimetic drug treatment,
- Subject under safeguard of justice,
- Subject participating in another search,
- Subject during pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe POISSON, Dr
University Hospital, Bordeaux
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2019
First Posted
August 14, 2019
Study Start
September 9, 2011
Primary Completion
June 29, 2012
Study Completion
June 29, 2012
Last Updated
August 14, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share